Literature DB >> 7598490

Transgenic animal models for detection of in vivo mutations.

J C Mirsalis1, J A Monforte, R A Winegar.   

Abstract

Transgenic rodent models for measuring mutations provide a tool for assessing tissue-specific mutations following in vivo treatment. These systems are based on the insertion into the rodent genome Escherichia coli lacI (lac repressor) or lacZ (beta-galactosidase) genes that serve as targets for mutations. Following in vivo treatment of animals, genomic DNA is isolated from tissues of interest, and the target gene is screened for mutations using either lambda-phage packaging or isolation of the target gene with magnetic affinity capture. In this paper we review the various experimental methods used in the conduct of transgenic mutation assays and discuss critical factors that affect the interpretations of results of these assays.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7598490     DOI: 10.1146/annurev.pa.35.040195.001045

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  8 in total

1.  Epigenetic regulation of genetic integrity is reprogrammed during cloning.

Authors:  Patricia Murphey; Yukiko Yamazaki; C Alex McMahan; Christi A Walter; Ryuzo Yanagimachi; John R McCarrey
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-02       Impact factor: 11.205

Review 2.  High-throughput sequencing in mutation detection: A new generation of genotoxicity tests?

Authors:  Alexander Y Maslov; Wilber Quispe-Tintaya; Tatyana Gorbacheva; Ryan R White; Jan Vijg
Journal:  Mutat Res       Date:  2015-04-20       Impact factor: 2.433

3.  Chromosome instability contributes to loss of heterozygosity in mice lacking p53.

Authors:  C Shao; L Deng; O Henegariu; L Liang; P J Stambrook; J A Tischfield
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

4.  Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage lambda transgene target.

Authors:  J L Jakubczak; G Merlino; J E French; W J Muller; B Paul; S Adhya; S Garges
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

5.  Tumors of DNA mismatch repair-deficient hosts exhibit dramatic increases in genomic instability.

Authors:  A Baross-Francis; S E Andrew; J E Penney; F R Jirik
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

Review 6.  Occupational cancer in France: epidemiology, toxicology, prevention, and compensation.

Authors:  J C Aubrun; S Binet; C Bozec; P Brochard; S Dimerman; B Fontaine; P Guénel; D Luce; Y Martinet; J J Moulin; J M Mur; M Pietruszynski; C Vallayer
Journal:  Environ Health Perspect       Date:  1999-05       Impact factor: 9.031

7.  Mutagenicity testing with transgenic mice. Part II: Comparison with the mouse spot test.

Authors:  Ulrich Wahnschaffe; Annette Bitsch; Janet Kielhorn; Inge Mangelsdorf
Journal:  J Carcinog       Date:  2005-01-27

8.  Mutagenicity testing with transgenic mice. Part I: Comparison with the mouse bone marrow micronucleus test.

Authors:  U Wahnschaffe; A Bitsch; J Kielhorn; I Mangelsdorf
Journal:  J Carcinog       Date:  2005-01-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.